RE: MTBE misclassified
Dr. Mehlman's commentary on the decision not to list methyl‐tertiary butyl ether (MTBE) in the NTP 9th Report on Carcinogens correctly raises process questions, but also leads back to the public health fundamentals of motor fuel toxicity. I was a voter in the minority for listing MTBE, and also...
Gespeichert in:
Veröffentlicht in: | American journal of industrial medicine 2001-05, Vol.39 (5), p.509-510 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Dr. Mehlman's commentary on the decision not to list methyl‐tertiary butyl ether (MTBE) in the NTP 9th Report on Carcinogens correctly raises process questions, but also leads back to the public health fundamentals of motor fuel toxicity. I was a voter in the minority for listing MTBE, and also a peer reviewer for the revised criteria for listing substances some years ago. Dr. Mehlman's commentary brings to light a prime example of "Houdini Risk Assessments", risk assessments which make the risk disappear and, therefore, allow industry to escape preventive measures. |
---|---|
ISSN: | 0271-3586 1097-0274 |
DOI: | 10.1002/ajim.1045 |